<DOC>
	<DOC>NCT02300441</DOC>
	<brief_summary>A prospective cohort pilot study of non-cardiac patients to determine the feasibility of recruiting 150 patients to undergo postoperative continuous hemodynamic monitoring for up to 3 days.</brief_summary>
	<brief_title>HI-VISION Pilot Study</brief_title>
	<detailed_description>Patient will start wearing the Philips' hemodynamic and ECG monitor in the Post Anaesthesia Care Unit (PACU). This device will continuously measure heart rate, pulse oxymetry, and ST-segments. The device will measure blood pressure every hour from 7 am to 10 pm and every 2 hours from 10 pm to 7 am. Patients will have postoperative Troponin I monitoring and telephone follow-up at 30 days postop.</detailed_description>
	<criteria>We will enroll patients aged 45 years or older undergoing noncardiac surgery who fulfilled 2 or more of the following risk factors: History of coronary artery disease History of stroke or transient ischemic attack (TIA) History of hypertension History of diabetes History of peripheral vascular disease History of congestive heart failure Preoperative creatinine &gt; 175 umol/L A planned admission for â‰¥48 hours Patients receiving a general or regional anesthetic Patients unable to provide informed consent. Patients who undergo procedure performed under infiltrative or topical anesthesia. Patients previously enrolled in the HIVISION Study. Patients who refuse 30day followup.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>